Drugs with this side effect as MedDRA Preferred Term
- Dexmedetomidine
- Myocardial infarction: postmarketing
- Imagent
- Tacrine Hydrochloride Capsules
- Myocardial infarction: infrequent
- Tolcapone
- acamprosate calcium
- Myocardial infarction: infrequent
- almotriptan
- Myocardial infarction: postmarketing
- amifostine
- amitriptyline
- amlodipine
- amoxapine
- Myocardial infarction: postmarketing
- amphotericin b
- Myocardial infarction: postmarketing
- anagrelide hydrochloride
- anastrozole
- Myocardial infarction: postmarketing, 13% - 19%
- aprotinin
- Myocardial infarction: postmarketing
- argatroban
- Myocardial infarction: 3.57% - 3.6%
- aripiprazole
- Myocardial infarction: infrequent
- azilect
- Myocardial infarction: infrequent
- benazepril
- Myocardial infarction: postmarketing
- betaxolol
- bezafibrate
- bicalutamide
- bisoprolol fumarate
- bleomycin sulfate
- Myocardial infarction: postmarketing
- bortezomib
- Myocardial infarction: postmarketing
- bromocriptine
- Myocardial infarction: postmarketing
- bupropion
- Myocardial infarction: postmarketing
- buspirone
- Myocardial infarction: rare
- calcitonin salmon
- candesartan cilexetil
- capecitabine
- carbamazepine
- cefdinir
- Myocardial infarction: postmarketing
- celecoxib
- Myocardial infarction: postmarketing
- cevimeline hydrochloride
- cilazapril (cilazapril monohydrate)
- Myocardial infarction: postmarketing
- ciprofloxacin
- Myocardial infarction: postmarketing
- cisplatin
- citalopram
- Myocardial infarction: postmarketing, infrequent
- clomipramine
- Myocardial infarction: rare
- clozapine
- Myocardial infarction: postmarketing
- cortisone
- crixivan
- Myocardial infarction: postmarketing
- cyclobenzaprine
- Myocardial infarction: postmarketing
- cyclophosphamide
- cyclosporine
- Myocardial infarction: postmarketing
- cyproterone acetate
- danazol
- decitabine
- desflurane
- Myocardial infarction: postmarketing
- desipramine
- desmopressin acetate
- Myocardial infarction: postmarketing
- desvenlafaxine
- dexamethasone
- dextroamphetamine sulfate
- diatrizoic acid
- diazoxide
- diclofenac
- Myocardial infarction: postmarketing
- dihydroergotamine
- diltiazem
- Myocardial infarction: postmarketing
- dinoprostone
- dipyridamole
- docetaxel
- Myocardial infarction: postmarketing
- dofetilide
- dolasetron mesylate
- Myocardial infarction: postmarketing
- donepezil
- Myocardial infarction: infrequent
- doxazosin
- Myocardial infarction: postmarketing
- duloxetine
- Myocardial infarction: postmarketing, infrequent
- enalapril sodium
- epoprostenol sodium
- esmolol hydrochloride
- Myocardial infarction: postmarketing
- estramustine phosphate sodium
- estrogens, conjugated
- Myocardial infarction: postmarketing
- etodolac
- Myocardial infarction: postmarketing
- etoposide
- etravirine
- exemestane
- febuxostat
- felodipine
- Myocardial infarction: postmarketing
- fenofibrate
- Myocardial infarction: postmarketing
- fenoldopam
- fentanyl
- fludarabine
- Myocardial infarction: postmarketing
- fluorouracil
- fluoxetine
- Myocardial infarction: rare, infrequent
- flurbiprofen
- Myocardial infarction: postmarketing
- fluvoxamine maleate
- Myocardial infarction: rare, infrequent
- fondaparinux sodium
- Myocardial infarction
- Acute coronary syndrome: postmarketing
- formoterol fumarate
- fosaprepitant dimeglumine
- fosinopril sodium
- frovatriptan
- gabapentin
- Myocardial infarction: rare, infrequent
- gadobenic acid
- gadodiamide
- gadofosveset
- gadopentetate dimeglumine
- Myocardial infarction: postmarketing
- gemcitabine
- Myocardial infarction: postmarketing
- glatiramer acetate
- Myocardial infarction: postmarketing
- gliclazide
- goserelin
- Myocardial infarction: postmarketing
- guanfacine
- Myocardial infarction: postmarketing
- heparin
- hydrochlorothiazide
- hydrocortisone
- hyoscyamine
- ibuprofen
- imipramine
- imiquimod
- Myocardial infarction: postmarketing
- insulin recombinant human
- iodine
- iodixanol
- iopamidol
- ioversol
- irbesartan
- irinotecan
- isosorbide-5-mononitrate
- ketoprofen
- Myocardial infarction: postmarketing
- ketorolac
- Myocardial infarction: postmarketing
- lamotrigine
- Myocardial infarction: rare
- lansoprazole
- Myocardial infarction: postmarketing
- lenalidomide
- letrozole
- Myocardial infarction: 0.98% - 1.51%
- leuprolide acetate
- Myocardial infarction: postmarketing
- levitra
- levofloxacin
- liothyronine
- maraviroc
- maxaquin
- medroxyprogesterone acetate
- Myocardial infarction: postmarketing
- mefenamic acid
- memantine hydrochloride
- Myocardial infarction: infrequent
- meropenem
- methylergonovine
- methylnaltrexone bromide
- Myocardial infarction
- Acute coronary syndrome
- methylprednisolone
- metipranolol
- micafungin sodium
- mirtazapine
- Myocardial infarction: infrequent
- misoprostol
- Myocardial infarction: postmarketing
- mitoxantrone
- moexipril hydrochloride
- moricizine
- moxifloxacin hydrochloride
- Myocardial infarction: postmarketing
- nabumetone
- Myocardial infarction: postmarketing
- naltrexone
- Myocardial infarction: postmarketing
- naproxen
- Myocardial infarction: postmarketing
- naratriptan
- Myocardial infarction: postmarketing
- nicardipine
- nifedipine
- nilotinib (nilotinib hydrochloride monohydrate)
- nisoldipine
- norfloxacin
- ondansetron
- oxaprozin
- paclitaxel
- Myocardial infarction: postmarketing
- pantoprazole
- paroxetine
- Myocardial infarction: rare, postmarketing
- pergolide mesylate
- Myocardial infarction: infrequent, 1% - 1.1%
- phenylephrine
- pilocarpine
- pioglitazone (pioglitazone hydrochloride)
- Acute coronary syndrome: 2.5%
- piroxicam
- porfimer sodium
- posaconazole
- pramipexole dihydrochloride monohydrate
- prednisolone
- prednisone
- pregabalin
- prezista
- propofol
- Myocardial infarction: postmarketing
- propoxyphene
- protriptyline
- quinapril
- rabeprazole sodium
- ranolazine
- relpax
- repaglinide
- riluzole
- risperidone
- Myocardial infarction: infrequent
- ritonavir
- Myocardial infarction: postmarketing
- rivastigmine
- Myocardial infarction: frequent
- rizatriptan (rizatriptan benzoate)
- Myocardial infarction: postmarketing
- rofecoxib
- Myocardial infarction: postmarketing
- ropinirole
- Myocardial infarction: infrequent
- Acute coronary syndrome: infrequent
- ropivacaine hydrochloride
- rosiglitazone maleate
- sapropterin
- selegiline
- Myocardial infarction: rare
- sertraline
- Myocardial infarction: rare
- sildenafil
- Myocardial infarction: postmarketing
- sitaxsentan sodium
- sprycel
- Myocardial infarction: infrequent
- Acute coronary syndrome: rare
- sumatriptan (sumatriptan succinate)
- Myocardial infarction: postmarketing
- sutent
- tacrolimus
- Myocardial infarction: postmarketing
- tadalafil
- Myocardial infarction: postmarketing
- talc
- tamoxifen citrate
- tarceva
- thalidomide
- tiagabine hydrochloride
- Myocardial infarction: infrequent
- tizanidine
- Myocardial infarction: rare
- toremifene
- tracleer
- tramadol
- trazodone
- Myocardial infarction: postmarketing
- tretinoin
- triamcinolone
- trusopt
- ursodiol
- valdecoxib
- varenicline
- Myocardial infarction: postmarketing, infrequent
- Acute coronary syndrome: rare
- venlafaxine
- Myocardial infarction: rare
- venofer
- Myocardial infarction: postmarketing
- verapamil
- Myocardial infarction: postmarketing
- vincristine
- vinorelbine
- voriconazole
- Myocardial infarction: postmarketing
- welchol
- zolmitriptan
- Myocardial infarction: postmarketing
- zolpidem
- Myocardial infarction: rare
|
Drugs with this indication
|